Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
DCA Pharmacy is recalling 129 vials of Sermorelin 6mg/6mL Lyophilized Powder because an FDA inspection found it was not compounded in an appropriate area, potentially compromising sterility.
Hartley Medical Center Pharmacy is recalling 10 vials of Prolotherapy with Phenol due to non-sterility concerns. The product was distributed in California and Nevada.
Hartley Medical Center Pharmacy is recalling 14 vials of Prolotherapy with Phenol due to non-sterility concerns. The product was distributed in California and Nevada.
Medistat RX L.L.C. is recalling all sterile products, including various injectable medications, due to a lack of assurance of sterility.
Eagle Pharmacy is recalling 104 vials of Lipo B Sterile Injection due to trace amounts of methylcobalamin. The product was distributed in Alabama and Tennessee.
PharMEDium Services is recalling 20 bags of Bupivacaine HCl 0.0625% for epidural use because they contain human hair particulate matter.
Pharmedium Services is recalling 120 bags of Phenylephrine HCl injection due to the presence of human hair particulate matter.
PharMEDium Services is recalling 100 bags of Morphine Sulfate IV solution because the sodium chloride used contained human hair.
Pharmedium Services, LLC is recalling specific lots of Phenylephrine HCl injection because the sodium chloride base used contained human hair.
Baxter Healthcare is recalling 139,104 bags of 0.9% Sodium Chloride Injection due to a reported complaint of mold on the interior surface of the overpouch.
Pharmedium Services, LLC is recalling 48 bags of Phenylephrine HCl injection due to the presence of particulate matter, specifically human hair, in the product.
Pharmedium Services is recalling 84 bags of Phenylephrine HCl injection because the sodium chloride base contained human hair.
Pharmedium Services is recalling specific lots of Phenylephrine HCl injection due to the presence of human hair particulate matter.
PharMEDium Services, LLC is recalling 663 bags of Fentanyl Citrate IV solution because the sodium chloride used contained human hair.
Hospira, Inc. is recalling Lidocaine Hydrochloride Injection vials because iron oxide particulate matter was found embedded in the glass vial necks.
The Compounding Pharmacy of America is recalling Hydromorphone 1 mg/ml Intrathecal Solution because FDA inspections found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Hydroxocobalamin and Folic Acid injectable vials due to FDA-identified GMP violations affecting sterility.
The Compounding Pharmacy of America is recalling a compounded intrathecal solution because an FDA inspection found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Hydromorphone and Bupivacaine solution because an FDA inspection found violations that may affect sterility.
The Compounding Pharmacy of America is recalling Mitomycin Injection due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Tri-Mix Injectable nationwide because an FDA inspection found GMP violations that may affect sterility.
The Compounding Pharmacy of America is recalling Lipovicine-Choline and Ascorbic Acid injectable vials because an FDA inspection identified GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Lipo-DEN III Injection due to FDA inspection findings of GMP violations that may impact sterility.
The Compounding Pharmacy of America is recalling Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 Injectable due to lack of assurance of sterility identified during an FDA inspection.
The Compounding Pharmacy of America is recalling Testosterone 50 mg Pellets because FDA inspections found GMP violations that may impact sterility.